PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
25168935-6	2015	GLUT1 antibody conjugation can effectively target the injected Fe3O4 NPs to GLUT1-positive tumor cells in infantile hemangioma.	ferryl iron	63-68	solute carrier family 2 member 1	Homo sapiens	0-5	
25168935-0	2015	MRI molecular imaging using GLUT1 antibody-Fe3O4 nanoparticles in the hemangioma animal model for differentiating infantile hemangioma from vascular malformation.	ferryl iron	43-48	solute carrier family 2 member 1	Homo sapiens	28-33	
25168935-1	2015	The purpose of this study is to evaluate the efficacy of glucose transporter protein 1 (GLUT1) antibody-conjugated iron oxide nanoparticles (Fe3O4 NPs) as magnetic resonance imaging (MRI) molecular imaging agents for differentiating infantile hemangioma from vascular malformation in the hemangioma animal model.	ferryl iron	141-146	solute carrier family 2 member 1	Homo sapiens	57-86	
25168935-1	2015	The purpose of this study is to evaluate the efficacy of glucose transporter protein 1 (GLUT1) antibody-conjugated iron oxide nanoparticles (Fe3O4 NPs) as magnetic resonance imaging (MRI) molecular imaging agents for differentiating infantile hemangioma from vascular malformation in the hemangioma animal model.	ferryl iron	141-146	solute carrier family 2 member 1	Homo sapiens	88-93	
25168935-2	2015	The conjugation of Fe3O4 NPs with anti-GLUT1 antibodies leads to a significantly increased uptake of NPs by human umbilical vein endothelial cells.	ferryl iron	19-24	solute carrier family 2 member 1	Homo sapiens	39-44	
25168935-3	2015	MRI imaging following the intravenous injection of GLUT1 antibody-Fe3O4 NPs yielded a significantly lower signal intensity than did unconjugated Fe3O4 NPs.	ferryl iron	66-71	solute carrier family 2 member 1	Homo sapiens	51-56	
25168935-4	2015	Upon histological examination of the GLUT1 antibody-Fe3O4 NPs, Prussian blue-stained NPs were identified in CD31-positive endothelial cells of hemangioma.	ferryl iron	52-57	solute carrier family 2 member 1	Homo sapiens	37-42	
25168935-6	2015	GLUT1 antibody conjugation can effectively target the injected Fe3O4 NPs to GLUT1-positive tumor cells in infantile hemangioma.	ferryl iron	63-68	solute carrier family 2 member 1	Homo sapiens	76-81	
24184535-2	2014	SiO2@indol-IL can inhibit the proliferation of HepG-2 cells in 48 h. Fe3O4@indol-IL can mimic the function of catalase to disproportionate H2O2 to O2, and has obvious effect on the proliferation of HepG-2 cells in 72 h. Moreover, the two nanoparticles show some inhibition on the expression of hypoxia inducible factor (HIF-1alpha), glucose transporter (GLUT1) and the production of lactate in HepG-2 cells.	ferryl iron	69-74	solute carrier family 2 member 1	Homo sapiens	354-359